egtazic acid has been researched along with Marchiafava-Micheli Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frank, MM; Jiang, H; Wagner, E; Zhang, H | 1 |
1 other study(ies) available for egtazic acid and Marchiafava-Micheli Syndrome
| Article | Year |
|---|---|
Complement 1 inhibitor is a regulator of the alternative complement pathway.
Topics: Absorption; Animals; Complement C1 Inactivator Proteins; Complement C3 Convertase, Alternative Pathway; Complement C3b; Complement Factor B; Complement Factor D; Complement Inactivator Proteins; Complement Pathway, Alternative; Egtazic Acid; Elapid Venoms; Erythrocytes; Glycoproteins; Hemoglobinuria, Paroxysmal; Hemolysis; Humans; Microspheres; Peptide Fragments; Rabbits; Sepharose | 2001 |